Anzeige
Mehr »
Donnerstag, 24.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.08.Navigating patient experience data in rare disease
04.08.Lilly's olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer
04.08.Congresses have evolved. Has your strategy?
03.08.Novartis' Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer
03.08.Patient-centred healthcare communications: why co-creation drives better creative ideas
31.07.AbbVie's Rinvoq approved by European Commission for non-segmental vitiligo
31.07.Forging a connection through creativity
30.07.Inizio launches Connected Insights
30.07.Pfizer announces phase 3 results for nonsegmental vitiligo treatment
29.07.Cases of skin cancer set to reach 263,000 in 2035 according to new report
29.07.Former Serviceplan Health Managing Partner launches new consultancy
28.07.Havas Lynx expands Claire Knapp's remit to oversee Havas Lynx New York
28.07.Johnson & Johnson commits $5.5bn to end remaining talc litigation
27.07.EMA recommends granting marketing authorisation approval for Nezglyal
27.07.MAD World Summit 2026: where the future of workplace well-being takes centre stage
24.07.AstraZeneca's Trixeo recommended by CHMP for approval in EU for asthma
24.07.ELRIG appoints Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board
23.07.Pfizer's Talzenna plus Xtandi gets FDA Priority Review for metastatic prostate cancer
23.07.Stoke Therapeutics appoints Thomas McCauley as Chief Scientific Officer
22.07.Takeda's zasocitinib shows high rates of skin clearance in phase 3 psoriasis studies
22.07.Richmond Pharmacology appoints Daniel Chapple as Commercial Director
21.07.Almirall's paediatric registration of Ebglyss for atopic dermatitis gets EMA acceptance
21.07.The Bloc appoints Jon Chapman as European Executive Creative Director
20.07.Camena Bioscience appoints Gregory McGuinness as CEO
20.07.Lilly to acquire AtaiBeckley in deal worth $2.8bn